Open Access

CDR1as/miR‑7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells

  • Authors:
    • Feng Zhao
    • Tongyun Chen
    • Nan Jiang
  • View Affiliations

  • Published online on: March 23, 2020     https://doi.org/10.3892/etm.2020.8622
  • Pages: 3760-3766
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Abdominal aortic aneurysm (AAA) is characterized as dilation of the aortic wall. Dysregulation of vascular smooth muscle cells (VSMCs) can contribute to the development of this phenotype. Circular RNAs and microRNAs (miRNAs) can regulate the proliferation and apoptosis of VSMCs. This present study aimed to identify the mechanisms of action behind the regulation of cerebellar degeneration‑related protein 1 antisense RNA (CDR1as)/miRNA (miR)‑7 in VSMCs. The expression levels of miR‑7 were upregulated, whereas the levels of CDR1as and cytoskeleton‑associated protein 4 (CKAP4) were downregulated in aortic specimens obtained from 10 patients who underwent surgery for AAA compared with aortic specimens from 10 control patients who underwent coronary artery bypass surgery. The molecular mechanism of action of CDR1as/miR‑7 was investigated in primary VSMCs. The results of Cell Counting kit‑8 and cell growth curve assays revealed that overexpression of CDR1as and knockdown of miR‑7, increased VSMC proliferation, whereas knockdown of CDR1as and overexpression of miR‑7 suppressed VSMC proliferation. In addition, overexpression of CDR1as and knockdown of miR‑7, suppressed apoptosis in VSMCs, indicated by the decreased levels of reactive oxygen species (ROS) and lactate dehydrogenase (LDH) activity, whereas knockdown of CDR1as and overexpression of miR‑7 exhibited the opposite effects. The results of luciferase reporter and biotin pull‑down assays confirmed that CDR1as directly bound to miR‑7 and suppressed its expression. Additionally, the CDR1as‑induced proliferation and suppressed apoptosis was reversed by the overexpression of miR‑7. Furthermore, luciferase reporter, reverse transcription‑quantitative PCR and western blot assays revealed that miR‑7 directly targeted CKAP4 and suppressed its expression. Additionally, the miR‑7‑suppressed proliferation and increased ROS and LDH activity were reversed by the overexpression of CKAP4. CDR1as also decreased caspase 3/7 activity, which was reversed by miR‑7 mimics. miR‑7 increased the activity of caspase 3/7, which was again reversed by the overexpression of CKAP4. Therefore, CDR1as, miR‑7 and CKAP4 may act in the same pathway to regulate VSMC proliferation and apoptosis.

Introduction

Abdominal aortic aneurysm (AAA) is a disease characterized by the dilation of the aorta that mostly affects adult patients, especially those >65 years (1). AAA can be life-threatening when an acute rupture occurs (2). Histological studies have revealed that AAA is associated with the impairment of apoptotic and inflammatory functions of vascular smooth muscle cells (VSMCs). VSMCs are the key source of elastin, which provides the elasticity of the aortic wall (3). VSMC apoptosis can reduce the levels of elastin, leading to the expansion of the aortic wall and ultimately resulting in alterations to the elasticity and remodeling of the abdominal aortic wall (4).

Non-coding RNAs (ncRNAs) are a class of non-protein coding RNAs that participate in numerous cellular processes and pathological conditions. This class includes microRNAs (miRNAs/miRs) and circular RNAs (circRNAs), among others (5). miRNAs have been demonstrated to be major post-transcriptional regulators of gene expression (6) and serve critical functions in vascular biology (7).

circRNAs interact with other molecules or miRNAs to regulate gene expression at the post-transcriptional or transcriptional levels (8), thus modulating various biological processes such as cell proliferation, apoptosis, invasion and migration (9). Cerebellar degeneration-related protein 1 antisense RNA (CDR1as) contains >70 binding sites to sponge miR-7 and modulate its activity on target genes (10). The CDR1as/miR-7 axis has been investigated in several types of cancer, such as esophageal squamous cell carcinoma and colorectal carcinoma (11). However, the functions of the CDR1as/miR-7 axis in AAA have not been investigated in detail.

Cytoskeleton-associated protein 4 (CKAP4), also termed p63 or cytoskeleton-linking membrane protein of 63 kDa, is a plasma membrane protein presented by VSMCs (12). Previous studies have suggested that CKAP4 may promote tumor progression through the PI3K/AKT (12) and cyclin B signaling pathways (13). CKAP4 and PI3K can form a complex at the proline-rich domain of CKAP4 and the Src homology 3 domain, which accelerates the production of phosphatidylinositol-3,4,5-triphosphate, leading to the activation of AKT and the proliferation of normal and cancer cells (13). Furthermore, the upregulation of CKAP4 increases the levels of cyclin B1 and cyclin B2, which in turn decreases cell population at the G2/M phase and increases cell population at the S phase, leading to the progression of clear cell renal cell carcinoma (14).

Previous studies have demonstrated that CDR1as can sponge miR-7 in osteosarcoma and hepatocellular carcinoma (11,15); therefore, the present study used bioinformatics analysis to predict that CKAP4 may be targeted by miR-7. The aim of the present study was to determine the relationship among CDR1as, miR-7 and CKAP4 in the pathogenesis of AAA, which may ultimately serve as a potential treatment target for AAA.

Materials and methods

Patient tissues

Aortic specimens were collected from 10 patients who underwent ascending aortic aneurysm surgery (mean age, 63.25±6.24; men, 7; women, 3) and from 10 control patients who underwent coronary artery bypass graft with non-aneurysmal aortas (mean age, 57.80±6.56; men, 8; women, 2) between January 2017 and December 2018 at Tianjin Chest Hospital. Patients with bicuspid aortic valves or hereditary connective tissue disorders were excluded from the control group. The obtained aortic specimens were split into two parts, which were snap-frozen in liquid nitrogen for RNA isolation or primary VSMCs isolation. All patients signed written informed consent, and ethical approval was obtained from the Institutional Review Board of Tianjin Chest Hospital.

Cell culture and transfection

Primary VSMCs were isolated from the aforementioned 10 clinical aortic specimens who underwent ascending aortic aneurysm surgery as previous described with modifications (16). Following removal of fat and connective tissue, the tissues were cut into 3-mm long sections and rubbed to remove the endothelium, mixed the 10 samples together, followed by incubation with 0.2% collagenase at 37˚C and centrifugation at 120 x g for 15 min at 4˚C to obtain VSMCs. Following washing with PBS, the obtained pelleted VSMCs were seeded into six-well plates containing medium 231 (cat. no. M231500; Life Technologies; Thermo Fisher Scientific, Inc.) containing 5% Smooth Muscle Growth Supplement (cat. no. S00725; Life Technologies; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin and streptomycin (cat. no. 15140122; Life Technologies; Thermo Fisher Scientific, Inc.), and incubated in under 5% CO2 at 37˚C for 24 h before transfection.

All the mimics and vectors were purchased from GeneCopoeia, Inc. For transfections, the miR-7 mimics (5'-UGGAAGACUAGUGAUUUUGUUGU-3'), miR-negative control (mimics NC, 5'-CAGUACUUUUGUGUAGUACAA-3'), miR-7 antisense oligonucleotide (miR-7 ASO, 5'-ACAACAAAAUCACUAGUCUUCCA-3'), ASO NC (5'-CAGUACUUUUGUGUAGUACAA-3'), small interfering RNA (si)-NC (5'-UUCUCCGAACGUGUCACGUTT-3'), si-CDR1as (5'-CCAAUAAGGCCAGUUCAUUTT-3') were used at 50 mM. pcDNA3 (abbr. NC), pcDNA3-CDR1as (abbr. CDR1as), pcDNA3-CKAP4 were used at 25 ng/ml in six-well plates seeded with 3x105 VSMCs cells. Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) was used for all transfections according to the manufacturer's instructions. The transfected cells were used for subsequent experiment at 48 h post-transfection.

Reverse transcription-quantitative PCR (RT-qPCR) analysis

TRIzol® (Invitrogen; Thermo Fisher Scientific, Inc.) was used for total RNA extraction from aortic specimens or VSMCs. Briefly, 1 µg of the RNA was reverse transcribed using the High-Capacity cDNA reverse transcription kit (cat. no. 4368813; Thermo Fisher Scientific, Inc.). The temperature protocol for reverse transcription was as follows: Incubation at 25˚C for 5 min, 37˚C for 120 min and 85˚C for 5 min. qPCR was then performed using SYBR Green Master mix (Thermo Fisher Scientific, Inc.) using the following parameters: 95˚C for 5 min; 40 cycles of 10 sec at 95˚C, 20 sec at 55˚C and 15 sec at 72˚C, followed by a melting curve of 10 sec at 95˚C, 60 sec at 60˚C and a continuous increase up to 95˚C at a rate of 0.15˚C/sec for 15 sec with a continuous reading of the fluorescence. The 2-ΔΔCq method was used to quantify the target gene expression (17). The primers used were as follows: miR-7 forward, 5'-CCACGTTGGAAGACTAGTGATTT-3' and reverse, 5'-TATGGTTGTTCTGCTCTCTGTCTC-3'; CDR1as forward, 5'-GTGTCTCCAGTGTATCGGCG-3' and reverse, 5'-TACTGGCACCACTGGAAACC-3'; GAPDH forward, 5'-GACTCATGACCACAGTCCATGC-3' and reverse, 5'-AGAGGCAGGGATGATGTTCTG-3'; U6 forward, 5'-CTCGCTTCGGCAGCACA-3' and reverse, 5'-AACGCTTCACGAATTTGCGT-3'.

Bioinformatics analysis

StarBase v3.0 (http://starbase.sysu.edu.cn) was used for predicting the potential long ncRNA (lncRNA) that can bind miR-7. TargetScan 7.1 (http://www.targetscan.org/vert_72/) was used to predict the downstream target genes of miR-7.

Luciferase reporter assay

Briefly, 1.5x104 cells were seeded in a 24-well plate. After 24 h, the cells were transfected with miR-7 mimics, miR-7 ASO, miR-NC or ASO NC as well as the pmirGLO vector (Promega Corporation), which was inserted with the wild-type (WT) 3'-untranslated region (UTR) of CKAP4 or a mutant (mut) form of CKAP4 3'-UTR which contained a mutated seed sequence (from 5'-GUCUUCC-3' into 5'-GUGUUGG-3'). At 48 h following transfection, the cells were used to measure the activities of firefly and Renilla luciferase using a Dual Luciferase reporter assay kit (Promega Corporation). The activity of Renilla luciferase was used as internal control.

Biotin pull-down assay

Cells were transfected with 50 µM of biotinylated miR-7 mimic or miR-NC (as aforementioned; GeneCopoeia, Inc.) for 24 h and lysed in 500 µl lysis buffer at 4˚C for 30 min, followed by the addition of 50 µl blocked streptavidin magnetic beads and incubation for 4 h at 4˚C. TRIzol® was used to extract the miR-7 that interacted with ncRNAs and the CDR1as expression levels were subsequently determined using RT-qPCR.

Western blot analysis

Following transfection for 48 h, the VSMCs were lysed using RIPA buffer (150 mM Tris-HCl, 50 mM NaCl, 1% Nonidet P-40 and 0.1% Tween-20), followed by determining the protein concentration using Bradford assays (Bio-Rad Laboratories, Inc.). Proteins (30 µg) were separated by 10% SDS-PAGE, followed by transferring to PVDF membranes at 250 mA for 2.5 h. After blocking for 1 h with 3% w/v skimmed milk at room temperature, the membranes were incubated with the following primary antibodies overnight at 4˚C: Anti-CKAP4 (cat. no. ab84712; 1:2,000; Abcam), anti-cleaved-caspase 3 (cat. no. 9661; 1:1,000; Cell Signaling Technology, Inc.) and anti-GAPDH (cat. no. 2118; 1:10,000; Cell Signaling Technology, Inc.). The next day, the membranes were washed with Tris-buffered saline containing 0.1% Tween 20, three times and incubated with a secondary antibody conjugated with horseradish peroxidase (cat. no. A0208, Beyotime Institute of Biotechnology) at 1:1,000 for 1 h at room temperature. Chemiluminescence was detected with an ECL kit (GE Healthcare Life Sciences), then quantified using ImageQuant software version 5.2 (GE Healthcare Life Sciences). GAPDH was used as an internal control.

Cell Counting Kit-8 (CCK-8) assay

To detect cell viability, a CCK-8 assay was performed. Treated and untreated VSMCs were cultured in a 96-well plate at 3x104 cells/well. After 48 h, 10% CCK-8 solution (Dojindo Molecular Technologies, Inc.) was added to each well and incubated for 1 h at 37˚C, as per the manufacturer's instructions, followed by analysis using a microplate reader at a wavelength of 450 nm.

Lactate dehydrogenase (LDH), reactive oxygen species (ROS) and caspase3/7 detection assays

To detect the extent of VSMC apoptosis, LDH, ROS and caspase 3/7 assays were performed.

For the LDH assay, transfected cells were cultured at 5x103 cells/well in 96-well plates for 48 h. After centrifuging at 350 x g for 5 min at 4˚C and discarding of the supernatant, 150 µl LDH release regent (cat. no. C0016; Beyotime Institute of Biotechnology) was added to each well and incubated for 1 h at 37˚C. The signal was detected using a microplate reader (Bio-Rad Laboratories, Inc.) at 490 nm.

Intracellular ROS was detected using 2',7'-dichlorofluorescin diacetate (DCF-DA; Sigma-Aldrich; Merck KGaA) staining as previously described (18). After discarding the cell medium, the cells (5x103 cells/well in 96-well plates) were stained with 20 µM DCF-DA solution at 37˚C in the dark for 30 min, followed by the measurement of the signal with a fluorescence reader (Bio-Rad Laboratories, Inc.) at excitation/emission wavelengths of 488/525 nm.

Caspase 3/7 activity was quantitated using a Caspase-Glo® 3/7 Assay kit (Promega Corporation) according to the manufacturer's instructions.

Statistical analysis

Data are presented as the mean ± standard error of the mean. When comparing the AAA aortic tissues and normal controls, data are presented using box and whiskers plots. Statistical analysis was performed using GraphPad Prism 8 software (GraphPad Software, Inc.) with one-way ANOVAs followed by Tukey's test. P<0.05 was considered to indicate a statistically significant difference. All experiments were repeated at least three times.

Results

miR-7 is upregulated, whereas CDR1as and CKAP4 are downregulated in AAA tissues

The results of RT-qPCR demonstrated that miR-7 was expressed at higher levels in AAA aortic tissues compared with the normal controls (Fig. 1A). The expression levels of CDR1as and CKAP4 were notably downregulated in AAA (Fig. 1B and C).

Effects of CDR1as and miR-7 on the function of primary VSMCs

Transfection efficiency of CDR1as overexpression plasmids and siRNA, and miR-7 mimics and ASO was evaluated using RT-qPCR. The results revealed that CDR1as overexpression increased CDR1as RNA levels 2-fold, whereas si-CDR1as downregulated the expression of this RNA by 60%. miR-7 mimics upregulated miR-7 expression 1.8-fold, whereas miR-7 ASO downregulated its expression by 70% (Fig. 2A). The results of the CCK-8 assay revealed that cell viability was increased following transfection with either CDR1as or miR-7 ASO, but decreased following transfection with siRNA CDR1as or miR-7 mimics, compared with their respective controls (Fig. 2B). Similarly, Cell growth curve assay showed that cell proliferative ability was increased following transfection with CDR1as or miR-7 ASO, but decreased following transfection with siRNA CDR1as or miR-7 mimics (Fig. 2C and D). In addition, CDR1as and miR-7 ASO decreased the ROS generation and LDH activity, which was increased following transfection with siRNA CDR1as or miR-7 mimics, compared with the respective control groups (Fig. 2E and F). These results suggested that CDR1as and miR-7 exerted opposing effects on VSMCs.

Overexpression of miR-7 reverses the effects of CDR1as in VSMCs

The WT version of CDR1as was found to contain a potential binding site of miR-7 (Fig. 3A). To further investigate whether miR-7 can be sponged by CDR1as in VSMCs, a CDR1as luciferase reporter was constructed. The results demonstrated that miR-7 significantly reduced the luciferase intensity of CDR1as-WT, but had no significant effect on the luciferase intensity of CDR1as-mut (Fig. 3B). In addition, the biotin pull-down assay results revealed that CDR1as was pulled down in biotinylated miR-7-transfected cells by 11-fold compared with cells transfected with biotinylated miR-NC (Fig. 3C). As presented in Fig. 3D, miR-7 expression was suppressed by CDR1as in VSMCs, which could be reversed by co-transfection with miR-7 mimics. CCK-8 and cell proliferation curve assays revealed that the CDR1as-facilitated cell viability and proliferation was reversed by co-transfection with miR-7 (Fig. 3E and F). Additionally, CDR1as-mediated suppression of ROS generation and LDH activity was reversed by co-transfections with miR-7 (Fig. 3G and H). Therefore, these data suggested that miR-7 may be sponged by CDR1as and mediate the downstream effects of CDR1as in VSMCs.

CKAP4 serves as a direct target of miR-7

Bioinformatics analysis was performed using TargetScan to predict the potential target of miR-7, with CKAP4 being identified as a target for miR-7 (Fig. 4A). To confirm whether CKAP4 was regulated by miR-7, RT-qPCR and western blot analysis were performed, which demonstrated that overexpression of miR-7 notably downregulated the expression of CKAP4 compared with mimics NC, whereas knockdown of miR-7 upregulated the expression of CKAP4 compared with ASO NC (Fig. 4B and C). In addition, luciferase reporter assays confirmed that miR-7 mimics notably decreased the luciferase activity of CKAP4-3'UTR, whereas this was not observed with miR-7 ASO. The expression of miR-7 mimics and ASO had no significant effects on the luciferase activity of the CKAP4-3'UTR mut reporter plasmid (Fig. 4D). These data confirmed that CKAP4 was a direct target of miR-7 in VSMCs.

CDR1as/miR-7/CKAP4 axis is involved in the regulation of the apoptosis proteins, caspase-3/7

To investigate whether CDR1as/miR-7/CKAP4 regulated the function of VSMCs, the present study investigated the impact of miR-7 on CKAP4. Firstly, pcDNA3-CKAP4 was verified to have an effective transfection efficiency (Fig. 5A). It was then confirmed that miR-7-mediated suppression of CKAP4 could be rescued by transfection with pcDNA3-CKAP4 (Fig. 5B). miR-7 mediated induction of caspase 3/7 activity can be rescued by co-transfection pcDNA3-CKAP4 with miR-7 mimics (Fig. 5C), which suggested that miR-7-induced apoptosis may be rescued by CKAP4. In addition, the results demonstrated that CDR1as upregulated the expression of CKAP4, which was reversed by co-transfection with CDR1as and miR-7 mimics (Fig. 5D). The CDR1as-reduced caspase 3/7 activity by was rescued following co-transfection with miR-7 mimics (Fig. 5E), suggesting that the CDR1as-mediated suppression of apoptosis was dependent on the downregulation of miR-7. In summary, CDR1as mediated the downregulation of miR-7, resulting in the upregulation of CKAP4 and leading to the inhibition of caspase 3/7 activity (Fig. 5F).

Discussion

A previous study has demonstrated that miR-7 can be sponged or inhibited by CDR1as in the developing midbrain of zebrafish, suggesting a newly identified mechanism of action for miRNA regulation (19). Further studies have confirmed that CDR1as promotes cell proliferation in hepatocellular carcinoma (15) and osteosarcoma (11) by suppressing miR-7 expression levels. The results of the present study demonstrated that CDR1as was expressed at a lower level, whereas miR-7 was upregulated in aortic tissue from patients with AAA compared with that of normal tissue. In addition, the predicted miR-7 target CKAP4 was downregulated in AAA tissue compared with normal tissue. A previous study has identified that AAAs are associated with apoptosis of VSMCs (20). Therefore, the upregulated miR-7 and the downregulated CDR1as and CKAP4 may affect apoptosis in VSMCs.

Primary VSMCs were used in the present study to investigate the mechanism of action of CDR1as/miR-7, aiming to identify the mechanisms behind the pathogenesis in AAAs. In a myocardial infarction (MI) study, CDR1as promoted MI injuries by reducing miR-7a activity (21). CDR1as is also downregulated and miR-7 is upregulated in patients with Alzheimer's disease (22). In tumorigenesis, CDR1as commonly serves as an oncogene in hepatocellular carcinoma (15), osteosarcoma (11) and non-small cell lung cancer (23). The results of the present study suggested that CDR1as may promote the proliferation and suppress the ROS generation and LDH activity of VSMCs, whereas co-expression of miR-7 can reverse the CDR1as-mediated effects. In addition, the results suggested that CDR1as may directly bind miR-7 in VSMCs. A previous study has demonstrated that ROS dysregulates the function of the extracellular matrix, thus promoting the apoptosis of VSMCs (24), which suggested that the CDR1as/miR-7 axis may contribute to the remodeling of AAA.

Studies on miR-7 have been conducted in different types of tumors, and its function as a tumor suppressor has been demonstrated in pancreatic cancer (25) and glioma (26). In VSMCs derived from AAA in the present study, miR-7 suppressed proliferation and promoted the generation of ROS as well as LDH activity. In addition, CKAP4 was confirmed to be a direct target for miR-7. Overexpression of CKAP4 reversed the miR-7-mediated effects on VSMCs. As the receptor of dickkopf-related protein 1 (DKK1), CKAP4 mediates downstream signaling to promote cellular proliferation and inhibit apoptosis through the activation of the PI3K/AKT pathway (27). Apoptosis of VSMCs is crucial for normal vascular remodeling (28). The PI3K/AKT signaling pathway is implicated in the proliferation of VSMCs, thus modulating vascular remodeling by decreasing the pro-apoptotic functions of Bcl2-associated death promoter (29,30).

The results of the present study demonstrated that CKAP4 suppressed the activity of caspase 3/7 and that miR-7-mediated increase in caspase 3/7 activity could be reversed by the overexpression of CKAP4 in VSMCs. In addition, CDR1as-suppressed caspase 3/7 activity was rescued by miR-7 overexpression. Thus, the activation of CDR1as in AAA may result in the downregulation of miR-7 and upregulation of CKAP4. This in turn may activate the PI3K/AKT pathway and result in the interference in the function of DKK1, leading to VMSC remodeling.

In conclusion, the results of the present study identified the functions of the CDR1as/miR-7/CKAP4 axis in VSMCs from patients with AAA and demonstrated that upregulated CDR1as served as an inhibitor of miR-7. This increased the expression of CKAP4 to facilitate the proliferation and suppress the apoptosis of VSMCs, leading to VSMC remodeling and progression of AAA. This newly identified mechanism may provide novel options for the treatment of AAA.

Acknowledgements

Not applicable.

Funding

The current study was supported by Tianjin Commission of Science and Technology, grant no. 18ZXDBSY00160 (grant title: The treatment of aortic dissection in aged population of Tianjin) and grant. no. 16ZXMJSY00160 (grant title: The clinical research on Transcatheter Aortic Valve Implantation).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

FZ and TC performed the experiments, FZ wrote the manuscript. NJ designed the experiments. All authors read and approved the final manuscript.

Ethics and approval

Ethics and approval were obtained from the Institutional Review Board of Tianjin Chest Hospital. All patients signed written informed consent.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Scott RA, Bridgewater SG and Ashton HA: Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 89:283–285. 2002.PubMed/NCBI View Article : Google Scholar

2 

Reimerink JJ, van der Laan MJ, Koelemay MJ, Balm R and Legemate DA: Systematic review and meta-analysis of population-based mortality from ruptured abdominal aortic aneurysm. Br J Surg. 100:1405–1413. 2013.PubMed/NCBI View Article : Google Scholar

3 

Cao X, Cai Z, Liu J, Zhao Y, Wang X, Li X and Xia H: miRNA-504 inhibits p53-dependent vascular smooth muscle cell apoptosis and may prevent aneurysm formation. Mol Med Rep. 16:2570–2578. 2017.PubMed/NCBI View Article : Google Scholar

4 

Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, Timaran CH, Upchurch GR Jr and Veith FJ: Society for Vascular Surgery. The care of patients with an abdominal aortic aneurysm: The society for vascular surgery practice guidelines. J Vasc Surg. 50 (4 Suppl):S2–S49. 2009.PubMed/NCBI View Article : Google Scholar

5 

Ding L, Ren J, Zhang D, Li Y, Huang X, Ji J, Hu Q, Wang H, Ni Y and Hou Y: The TLR3 agonist inhibit drug efflux and sequentially consolidates low-dose cisplatin-based chemoimmunotherapy while reducing side effects. Mol Cancer Ther. 16:1068–1079. 2017.PubMed/NCBI View Article : Google Scholar

6 

Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004.PubMed/NCBI View Article : Google Scholar

7 

Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang Y, He Z, Wang Y and Li J: Circular RNAs: Regulators of cancer-related signaling pathways and potential diagnostic biomarkers for human cancers. Theranostics. 7:3106–3117. 2017.PubMed/NCBI View Article : Google Scholar

8 

Zhao ZJ and Shen J: Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 14:514–521. 2017.PubMed/NCBI View Article : Google Scholar

9 

Lasda E and Parker R: Circular RNAs: Diversity of form and function. RNA. 20:1829–1842. 2014.PubMed/NCBI View Article : Google Scholar

10 

Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013.PubMed/NCBI View Article : Google Scholar

11 

Xu B, Yang T, Wang Z, Zhang Y, Liu S and Shen M: CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value. Cancer Manag Re. 10:4871–4880. 2018.PubMed/NCBI View Article : Google Scholar

12 

Chan CYT, Cheuk BLY and Cheng SWK: Abdominal aortic aneurysm-associated MicroRNA-516a-5p regulates expressions of methylenetetrahydrofolate reductase, matrix metalloproteinase-2, and tissue inhibitor of matrix metalloproteinase-1 in human abdominal aortic vascular smooth muscle cells. Ann Vasc Surg. 42:263–273. 2017.PubMed/NCBI View Article : Google Scholar

13 

Kimura H, Fumoto K, Shojima K, Nojima S, Osugi Y, Tomihara H, Eguchi H, Shintani Y, Endo H, Inoue M, et al: CKAP4 is a Dickkopf1 receptor and is involved in tumor progression. J Clin Invest. 126:2689–2705. 2016.PubMed/NCBI View Article : Google Scholar

14 

Sun CM, Geng J, Yan Y, Yao X and Liu M: Overexpression of CKAP4 is associated with poor prognosis in clear cell renal cell carcinoma and functions via cyclin B signaling. J Cancer. 8:4018–4026. 2017.PubMed/NCBI View Article : Google Scholar

15 

Yajima N, Masuda M, Miyazaki M, Nakajima N, Chien S and Shyy JY: Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: A study of the transcription profile with complementary DNA microarray. J Vasc Surg. 36:379–385. 2002.PubMed/NCBI View Article : Google Scholar

16 

Liang B, Wang S, Wang Q, Zhang W, Viollet B, Zhu Y and Zou MH: Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo. Arterioscler Thromb Vasc Biol. 33:595–604. 2013.PubMed/NCBI View Article : Google Scholar

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

18 

Yu L, Gong X, Sun L, Zhou Q, Lu B and Zhu L: The circular RNA Cdr1as act as an oncogene in hepatocellular carcinoma through targeting miR-7 expression. PLoS One. 11(e0158347)2016.PubMed/NCBI View Article : Google Scholar

19 

Stather PW, Sylvius N, Sidloff DA, Dattani N, Verissimo A, Wild JB, Butt HZ, Choke E, Sayers RD and Bown MJ: Identification of microRNAs associated with abdominal aortic aneurysms and peripheral arterial disease. Br J Surg. 102:755–766. 2015.PubMed/NCBI View Article : Google Scholar

20 

Su Z, Yang Z, Xu Y, Chen Y and Yu Q: MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 6:8474–8490. 2015.PubMed/NCBI View Article : Google Scholar

21 

Geng HH, Li R, Su YM, Xiao J, Pan M, Cai XX and Ji XP: The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PLoS One. 11(e0151753)2016.PubMed/NCBI View Article : Google Scholar

22 

Kumar L, Shamsuzzama Haque R, Baghel T and Nazir A: Circular RNAs: The emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol Neurobiol. 54:7224–7234. 2017.PubMed/NCBI View Article : Google Scholar

23 

Zhang X, Yang D and Wei Y: Overexpressed CDR1as functions as an oncogene to promote the tumor progression via miR-7 in non-small-cell lung cancer. Onco Targets Ther. 11:3979–3987. 2018.PubMed/NCBI View Article : Google Scholar

24 

Emeto TI, Moxon JV, Au M and Golledge J: Oxidative stress and abdominal aortic aneurysm: Potential treatment targets. Clin Sci (Lond). 130:301–315. 2016.PubMed/NCBI View Article : Google Scholar

25 

Xia J, Cao T, Ma C, Shi Y, Sun Y, Wang ZP and Ma J: miR-7 suppresses tumor progression by directly targeting MAP3K9 in pancreatic cancer. Mol Ther Nucleic Acids. 13:121–132. 2018.PubMed/NCBI View Article : Google Scholar

26 

Visani M, de Biase D, Marucci G, Cerasoli S, Nigrisoli E, Bacchi Reggiani ML, Albani F, Baruzzi A and Pession A: PERNO study group. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol Oncol. 8:417–430. 2014.PubMed/NCBI View Article : Google Scholar

27 

Tuffy KM and Planey SL: Cytoskeleton-associated protein 4: Functions beyond the endoplasmic reticulum in physiology and disease. ISRN Cell Biol. 2012:1–11. 2012.

28 

McCabe CD, Spyropoulos DD, Martin D and Moreno CS: Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer. Cancer Res. 69:1988–1996. 2008.PubMed/NCBI View Article : Google Scholar

29 

Jang SW, Liu X, Fu H, Rees H, Yepes M, Levey A and Ye K: Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem. 284:24512–24525. 2009.PubMed/NCBI View Article : Google Scholar

30 

Wang S, Wang Y, Jiang J, Wang R, Li L, Qiu Z, Wu H and Zhu D: 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway. Prostaglandins Other Lipid Mediat. 91:51–60. 2010.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

June-2020
Volume 19 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao F, Chen T and Jiang N: CDR1as/miR‑7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells. Exp Ther Med 19: 3760-3766, 2020
APA
Zhao, F., Chen, T., & Jiang, N. (2020). CDR1as/miR‑7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells. Experimental and Therapeutic Medicine, 19, 3760-3766. https://doi.org/10.3892/etm.2020.8622
MLA
Zhao, F., Chen, T., Jiang, N."CDR1as/miR‑7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells". Experimental and Therapeutic Medicine 19.6 (2020): 3760-3766.
Chicago
Zhao, F., Chen, T., Jiang, N."CDR1as/miR‑7/CKAP4 axis contributes to the pathogenesis of abdominal aortic aneurysm by regulating the proliferation and apoptosis of primary vascular smooth muscle cells". Experimental and Therapeutic Medicine 19, no. 6 (2020): 3760-3766. https://doi.org/10.3892/etm.2020.8622